{
    "nctId": "NCT02890082",
    "briefTitle": "Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, Prior Chemotherapy for Breast Cancer",
    "officialTitle": "Pilot Study of Preservation of Fertility by Ovarian Stimulation Associated With Tamoxifen, and Freezing Oocyte or Embryo Prior Chemotherapy for Breast Cancer",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "OTHER",
    "enrollmentCount": 102,
    "primaryOutcomeMeasure": "Assess the feasibility of ovarian stimulation combining tamoxifen with recombinant FSH (follicle stimulating hormone ) followed by oocyte vitrification and / or embryo freezing before chemotherapy for breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Aged between 18 and 40\n* infiltrating breast carcinoma histologically proven\n* Indication of adjuvant or neoadjuvant chemotherapy\n* T0-T1-T2-T3\n* N0-N1-N2a\n* M0 after staging\n* AMH \u22651 ng / mL and / or account antral follicles \u2265 5\n* HIV serology negative.\n\nExclusion Criteria:\n\n* breast cancer history\n* History of another cancer in the last 5 years, with the exception of basal cell skin cancer and squamous cell\n* patient in pregnancy\n* pulmonary embolism under 6 months\n* deep vein thrombosis of less than 6 months.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}